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Key messages
 ► People living with HIV are more likely to smoke than 
the general population and are at greater risk of 
harm caused by smoking; interventions are required 
to improve smoking cessation in this group.
 ► A simple intervention of asking about smoking and 
offering referral for smoking cessation was feasi-
ble and resulted in a significant uptake of referral; 
however, a large proportion of those referred did not 
attend, suggesting that ways of improving uptake of 
smoking cessation services for HIV-positive people 
are required.
 ► This article describes a simple intervention that was 
associated with increased numbers of smokers iden-
tified within an HIV service and an increased number 
of referrals to smoking cessation services compared 
with the time period before the intervention.
AbstrAct
Introduction People living with HIV (PLWH) are more likely 
to smoke than the general population and are at greater 
risk of smoking-related illness. Healthcare services need to 
address this burden of preventable disease.
Methods We evaluated the impact of a brief intervention 
that asked service users about smoking when they 
attended for ambulatory HIV care in London, UK, and 
offered referral to smoking cessation.
results Overall, 1548 HIV-positive individuals were asked 
about their smoking status over a 12-month period. Of this 
group, 385 (25%) reported that they were current smokers, 
372 (97%) were offered referral to smoking cessation 
services and 154 (40%) accepted this. We established an 
outcome of referral for 114 (74%) individuals. A total of 36 
(10% of smokers) attended stop smoking clinics and 16 
(4%) individuals were recorded as having quit smoking.
Discussion The simple intervention of asking PLWH 
about tobacco smoking and offering referral to smoking 
cessation services rapidly identified current smokers, 40% 
of whom accepted referral to smoking cessation services. 
This highlights the importance of promoting behaviour and 
lifestyle changes with every contact with health services. 
However, a large proportion of those referred were either 
not seen in local services or the outcome of referral could 
not be ascertained. If the risk of smoking-related morbidity 
among PLWH is to be reduced, more sustainable referral 
pathways and ways of improving uptake of smoking 
cessation services must be developed.
bAckgrounD
Tobacco smoking represents the most impor-
tant cause of avoidable premature death 
worldwide.1 Among people living with HIV 
(PLWH) with good access to antiretroviral 
therapy (ART), smoking is now estimated to 
be responsible for the loss of more life-years 
than HIV infection itself.2 PLWH in most 
resource-rich settings are more likely to smoke 
than the general population,3 4 and may be 
at greater risk of smoking-related comorbid-
ities, such as cardiovascular and respiratory 
disease,5 6 and some cancers.7 In the UK, while 
smoking rates have fallen in the general popu-
lation, this trend may be less apparent among 
PLWH,8 for instance, the multisite Antiretro-
virals, Sexual Transmission Risk and Attitudes 
study (which included evaluation of smoking 
attitudes and behaviours) found that 29% 
of PLWH were current smokers compared 
with 19% of the general population.3 There 
is, therefore, an urgent need to address the 
high prevalence of tobacco smoking among 
HIV-positive people and develop cost-effec-
tive services to meet this healthcare need.
Smoking cessation interventions have 
been shown to be cost-effective in many 
settings.9 These include the provision of very 
brief advice (VBA) by healthcare workers (a 
brief structured intervention consisting of 
assessing smoking behaviours and providing 
advice and specific recommendations to 
support smoking cessation), nicotine replace-
ment therapy, prescription of bupropion or 
varenicline and use of stop smoking clinics.10 
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To date, few studies have assessed these interventions in 
the context of HIV care services and none have done so 
in the UK.11 We sought to evaluate the impact of asking 
healthcare workers to systematically identify current 
smokers attending routine HIV ambulatory care appoint-
ments and provide VBA.
MethoDs
We conducted an observational study in an adult HIV 
care service (Royal Free London NHS Foundation Trust) 
between October 2014 and October 2015. Healthcare 
assistants (HCAs) and nursing staff were provided with 
training regarding the provision of VBA and given details 
of smoking cessation services prior to the start of the inter-
vention. Training was provided by the hospital in-house 
specialist stop smoking advisers and the National Centre 
for Smoking Cessation and Training website.12
HIV-positive individuals attending routine HIV ambu-
latory care appointments were asked about smoking 
status by HCAs and nursing staff. This was undertaken 
when routine observations (blood pressure and weight) 
were recorded in a cubical allowing patient privacy to be 
maintained. Patient self-report of whether they consid-
ered themselves to be a current smoker was documented; 
this was not objectively confirmed or more specifically 
defined. People with a new diagnosis of HIV or those 
transferring their care from another HIV care provider 
were specifically evaluated to ascertain whether uptake 
of stop smoking services in this group differed from the 
clinic population as a whole.
Individuals who reported that they were current 
smokers were given VBA and offered referral to smoking 
cessation services. National Health Service (NHS) stop 
smoking clinics offer focused support plus provision of 
nicotine replacement and medications (bupropion or 
varenicline) where appropriate. In line with national 
policy, those who accepted this were referred to services 
in their local area. In-house specialist smoking cessation 
services were not provided within the HIV care service.
Specific outcomes measured were: (i) the proportion 
of HIV-positive people reporting current smoking status, 
(ii) the uptake of smoking cessation referrals and (iii) the 
outcome of referral to local smoking cessation services.
Data regarding the uptake and outcome of referral to 
smoking cessation services were obtained by contacting 
these services directly and by a brief telephone question-
naire to the HIV-positive patients referred to services. 
The costs and yield in terms of smokers identified and 
numbers attending smoking cessation achieved by this 
intervention were estimated.
Data were compiled using Microsoft Excel and statis-
tical analysis was conducted using SPSS V.22 (IBM). To 
assess differences in the characteristics among HIV-pos-
itive people who smoked compared with those who did 
not, we performed univariable analysis using two-sided χ2 
tests for categorical variables and Mann-Whitney tests for 
continuous variables. All tests of significance used p<0.05 
as the threshold of statistical significance.
Patient and public involvement
This study was conducted with the intention of evaluating 
patient referral to smoking cessation clinics, based on 
feedback from patients that there was a demand for such 
a service. There was no formal patient/public involve-
ment in conduct of the study or analysis of the results.
results
Between October 2014 and October 2015, 1548 HIV-posi-
tive patients were asked about their smoking status, repre-
senting 47% of the total population served by this HIV 
clinic. Of these, 385 (25%, 95% CI 23% to 27%) reported 
being current smokers, 1145 (74%, 95% CI 73% to 76%) 
being non-smokers and for 18 patients, smoking status 
was not recorded (figure 1). Patients who smoked were 
more likely to be male (86% vs 68%, p<0.001), slightly 
younger (median 48 vs 51 years, p<0.001), more often of 
White ethnicity (71% vs 51%, p<0.001) and more likely 
to have acquired HIV through sex between men (66% vs 
49%, p<0.001) than non-smokers (table 1). Among those 
using ART, patients who smoked were more likely to have 
a detectable HIV viral load than those who did not (11% 
vs 7%, p=0.03).
Of the 385 people identified as current smokers, 372 
(97%) were given VBA regarding smoking cessation and 
offered referral to smoking cessation services. A total of 
154 (40%) of the 372 accepted this referral. There were 
no significant differences in the age, gender, route of 
transmission, blood CD4 T-cell count or levels of HIV 
suppression between those who did and did not accept 
referral to smoking cessation services. Individuals with 
a new diagnosis of HIV infection and those transferring 
their care from another HIV service were specifically 
evaluated; of the 25 individuals in this group who were 
offered referral to smoking cessation, 10 (44%) accepted 
this.
To allow for system delays, after a minimum of 3 months 
from when the referral was sent, we contacted the local 
smoking cessation clinics to determine the outcome of 
referrals. We were able to establish this in 114 (74%) of 
the 154 individuals referred. A total of 36 (32%) were 
recorded as having attended the smoking cessation clinic 
and 16 (14%) as having quit smoking; this, therefore, 
represents 4% of all smokers identified by the inter-
vention. Of the 16 who quit, 10 did so after attending 
an NHS stop smoking clinic, 2 attended a pharmacy 
smoking cessation service and 4 quit without any addi-
tional specific assistance.
cost and yield of the intervention
The estimated total cost to HIV care services of providing 
this additional intervention was estimated to be £2008, based 
on training three HCAs to deliver VBA, an additional 5 min 
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Figure 1 Flow chart of referrals. NHS, National Health Service.
when taking routine observations to establish and record 
smoking status and 6 min to deliver VBA for smokers and 
make referrals to stop smoking services (table 2). Under 
these conditions, the estimated costs were, therefore, £5.22 
for each smoker identified and £55.77 for each individual 
who attended stop smoking services.
DIscussIon
The harms of smoking and the beneficial effects of 
smoking cessation on health are well-established. All 
healthcare staff coming into contact with patients at risk 
have a role to play in helping smokers to quit, mainly 
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Table 1 Characteristics of smokers and non-smokers
Non-smokers (n=1108) Smokers (n=369) P value
Gender
Female, n (%) 354 (32%) 52 (14%) <0.001*
Male, n (%) 754 (68%) 317 (86%)
Age, years, median (IQR) 51 (45–56) 48 (43–54) <0.001†
Race/ethnic origin
Asian, n (%) 43 (3.9%) 7 (1.9%) <0.001*
Black, n (%) 393 (35.5%) 69 (18.7%)
Not stated, n (%) 16 (1.4%) 1 (0.3%)
Other/mixed, n (%) 79 (7.1%) 20 (5.4%)
White, n (%) 562 (50.7%) 264 (71.5%)
White and Asian, n (%) 1 (0.1%) 1 (0.3%)
White and Black African, n (%) 9 (0.8%) 2 (0.5%)
White and Black Caribbean, n (%) 5 (0.5%) 5 (1.4%)
Primary risk factor
Blood transfusion, n (%) 22 (2%) 0 <0.001*
Heterosexual sex, n (%) 497 (44.9%) 94 (25.5%)
Needle stick injury, n (%) 1 (0.1%) 0
Oral sex, n (%) 9 (0.8%) 1 (0.3%)
Other, n (%) 6 (0.5) 1 (0.3%)
Sex between men, n (%) 538 (48.6%) 244 (66.1%)
Shared syringes/needles, n (%) 16 (1.4%) 19 (5.1%)
Unknown, n (%) 12 (1.1%) 7 (1.9%)
Vertical transmission, n (%) 7 (0.6%) 3 (0.8%)
Patient on ART
No, n (%) 110 (10%) 52 (14%) 0.027*
Yes, n (%) 998 (90%) 317 (86%)
CD4 count, cells/µL, median (IQR) 590 (436–772) 684 (480–884) <0.001†
Undetectable HIV viral load‡
<40 copies/mL, n (%) 925 (93%) 282 (89%) 0.035*
>40 copies/mL, n (%) 73 (7%) 35 (11%)
Analysis restricted to 1108 non-smokers and 369 smokers identified in the clinical database.
*2 test.
†Mann-Whitney U test.
‡Only data from individuals using ART.
ART, antiretroviral therapy.
through triggering quit attempts by asking about smoking, 
delivering VBA on smoking and referring to stop smoking 
services.
The simple intervention of asking HIV-positive people 
about smoking when they attended HIV ambulatory 
care appointments and offering referral to stop smoking 
services to identified people who were current smokers, 
allowed VBA advice to be given and 40% of smokers 
accepted referral to smoking cessation services. This 
suggests that this intervention was acceptable to people 
with HIV and there is a demand for such services.
As with other interventions attempting to increase 
uptake of stop smoking services,13 most individuals offered 
referral did not take this up. The model of service provi-
sion in which dedicated smoking cessation services are 
not provided within HIV care, but instead individuals are 
referred to local services or primary care (depending on 
local commissioning decisions) may represent a barrier 
to their uptake for PLWH. Specifically targeted inter-
ventions in other groups with high smoking prevalence 
or risk of harm from smoking, such as individuals with 
peripheral vascular disease,14 diabetes15 or mental health 
problems,16 have been shown to improve uptake of stop 
smoking services. We believe that interventions tailored 
to the needs of PLWH should be evaluated. These might 
include personalised information about risk of harm from 
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Table 2 Cost and yield of intervention
Costs associated with intervention Unit time (hours) Hourly cost (£) N Total (£)
Staff training 4 11.25 4 180.00
Ask about smoking status and record 
result
0.08 11.25 1548 1451.25
Deliver VBA to smokers 0.08 11.25 372 348.75
Refer smokers 0.01 11.25 154 28.88
    Total cost of intervention 2008.88
Cost and yield of intervention
Smokers identified 385 Cost per identification £5.22
Smokers who attended SSS 36 Cost per SSS attendance £55.77
SSS, stop smoking services; VBA, very brief advice.
smoking,13 better communication between HIV care and 
stop smoking services or minimising barriers to access to 
such services within HIV care.
In the UK NHS setting, smoking cessation services have 
been shown to be cost-effective.17 The cost associated 
with the brief intervention we evaluated (estimated to be 
£55.77 for each person attending stop smoking clinic) 
was similar to that estimated in an evaluation by Wu et 
al of a personalised invitation from primary care to stop 
smoking clinic and appointment for a taster session, with 
an estimated mean cost of £54 per person. This was found 
to be cost-effective from an NHS perspective in the long-
term.18 Although few studies have comprehensively eval-
uated the economic impact of smoking cessation across 
a lifetime, available data suggest that there may be net 
savings from investing in smoking cessation.19 How this 
differs in HIV-positive groups in resource-rich settings 
has not been formally assessed, though the higher prev-
alence of smoking and greater risk of smoking-related 
illness is likely to increase these benefits—suggesting that 
this is a population who should be targeted specifically 
within smoking cessation policy.
The current means by which smoking cessation inter-
ventions are delivered, with few formalised links between 
HIV and smoking cessation services, may not be suited to 
the medical, social and psychological needs of PLWH. As a 
consequence, HIV services could miss this important oppor-
tunity to improve health outcomes. Alternative models 
of care, for instance, facilitating communication between 
services, training of HIV care providers to deliver smoking 
cessation assistance or specialist services directly linked to 
HIV care, should be evaluated. More importantly, asking 
about smoking and helping smokers to quit must become 
a core part of the care provided by all healthcare profes-
sionals involved with PLWH. Such an approach (described 
as ‘Making Every Contact Count’) can be a powerful means 
of generating lifestyle and behaviour change.20
The provision of smoking cessation interventions 
by the health service in England and Wales has under-
gone significant changes in recent years: responsibility 
for preventative public health interventions has moved 
from healthcare services to local authorities following 
the Health and Social Care Act 2012. Funding provided 
to local authorities from central government for public 
health interventions has subsequently been reduced 
and smoking cessation services have been one of the 
targets for cuts.21 At the same time, changes, such as the 
increased availability of e-cigarettes, have altered the 
way that some people consume nicotine and may be a 
means for some individuals to stop smoking, although 
this remains controversial.22 These changes have been 
associated with a significant reduction in the number of 
people accessing NHS stop smoking services.23 Within 
this changing landscape, HIV services must ensure that 
appropriate support for their patients is available.
This analysis has limitations which should be considered. 
Data collection was undertaken as part of clinical service 
evaluation and for a proportion of referrals made to stop 
smoking services so we could not establish the outcome of 
the referral, either because the service had no record of the 
referral or its outcome, or the smoking cessation service had 
been decommissioned since the time of referral. This illus-
trates the current deficiencies in communication between 
HIV and local smoking cessation services and the reduc-
tion in provision of universal smoking cessation services in 
the UK, as documented by recent national surveys.24 The 
proportion of HIV-positive individuals identified as current 
smokers by this intervention (25%) is lower than that 
found in other recent studies of PLWH in London, where 
around 30% were current smokers3 8—suggesting that not 
all smokers disclosed this when asked. Finally, the identifi-
cation of smokers relied on self-report, rather than being 
objectively confirmed (for instance with exhaled carbon 
monoxide measurements) and no objective measurement 
of quit rates (such as saliva cotinine levels) was performed. 
Despite these limitations, we believe that our report 
describing the potential benefit of low-cost smoking cessa-
tion interventions for the UK HIV-positive populations and 
the difficulties highlighted in the management of those 
smokers who wish to quit highlights the need for joined-up 
working to improve personal and public health within the 
NHS.
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